LL37

LL-37 – The Premier Human Cathelicidin Antimicrobial Peptide for Immune Defense, Wound Healing & Anti-Inflammatory Research.

Looking to Buy LL 37 Online? Among the most biologically significant and functionally versatile host defense peptides in the entire human innate immune arsenal, LL-37 occupies a uniquely important position in immunology, infection biology, and regenerative medicine research. As the only known human member of the cathelicidin family of antimicrobial peptides — naturally produced by neutrophils, macrophages, mast cells, and epithelial cells throughout the body — LL-37 serves as the front-line molecular defender against bacterial, viral, and fungal pathogens while simultaneously orchestrating wound healing, immune modulation, and cellular regeneration through a breadth of biological activity that no synthetic antibiotic can replicate. Find pharmaceutical-grade LL 37 peptide for sale now at Collagenpeptideseu — your verified, trusted source for premium research peptides.

What Is LL-37?

LL-37 is a 37-amino acid cationic helical peptide — the C-terminal fragment of the human cathelicidin precursor protein hCAP18 (human Cationic Antimicrobial Protein 18). The “LL” designation refers to the two leucine residues at the N-terminus of the mature peptide, while “37” denotes its amino acid count. First isolated and characterized in the early 1990s, LL-37 has since generated one of the most extensive research evidence bases of any host defense peptide in human biology — with published research spanning antimicrobial pharmacology, immunology, wound healing, cancer biology, and reproductive medicine.

The LL 37 cathelicidin peptide is unique among antimicrobial compounds in that it combines three distinct biological roles simultaneously:

1. Direct antimicrobial activity — membrane-disrupting action against bacteria, viruses, and fungi
2. Immune modulation — regulation of both innate and adaptive immune responses
3. Tissue repair and regeneration — wound healing, angiogenesis, and cellular migration promotion

This triple biological role makes LL 37 peptide research uniquely comprehensive — addressing infection defense, immune regulation, and tissue repair through a single endogenous peptide that evolution has refined over millions of years as the human body’s most versatile molecular defender.

LL-37 Antimicrobial Peptide – Mechanism of Action

The LL 37 antimicrobial peptide mechanism is fundamentally different from conventional antibiotics — operating through physical membrane disruption rather than specific molecular target inhibition:

Direct Antimicrobial Mechanism

LL-37’s cationic (positively charged) character and amphipathic alpha-helical structure enable it to selectively bind to the negatively charged membranes of bacterial, viral, and fungal pathogens — inserting into the membrane lipid bilayer and disrupting membrane integrity through pore formation and membrane solubilization. This physical membrane disruption mechanism:

• Kills bacteria rapidly — membrane disruption occurs within seconds to minutes of contact
• Prevents resistance development — physical membrane disruption is extremely difficult for pathogens to evolve resistance against
• Broad-spectrum activity — documented antimicrobial activity against gram-positive bacteria, gram-negative bacteria, fungi, and enveloped viruses
• Biofilm disruption — documented activity against established bacterial biofilms that conventional antibiotics cannot penetrate

Documented Antimicrobial Activity Against:

• Staphylococcus aureus (including MRSA)
• Pseudomonas aeruginosa
• Escherichia coli
• Candida albicans
• Influenza viruses
• HIV (indirect immune-mediated)
• Helicobacter pylori

LL-37 vs BPC-157 – Two Complementary Healing Peptides

The LL-37 vs BPC-157 comparison highlights two complementary approaches to wound healing and tissue repair:

The verdict: LL-37 and BPC-157 address wound healing and tissue repair through complementary, non-overlapping mechanisms — LL-37 providing antimicrobial protection and immune-mediated healing while BPC-157 drives biochemical tissue repair and angiogenesis. The most comprehensive wound healing and regenerative research protocols incorporate both peptides for complete coverage across all healing dimensions.

LL 37 Benefits – Complete Research Profile

LL-37 benefits documented across published research span multiple important physiological domains:

Antimicrobial & Infection Defense:

• Broad-spectrum direct antimicrobial killing — bacteria, viruses, and fungi
• Anti-biofilm activity — disrupts established biofilm communities resistant to conventional antibiotics
• Resistance-proof mechanism — physical membrane disruption prevents classical resistance development
• Synergistic with conventional antibiotics — enhances antibiotic efficacy through combined membrane-targeting

Immune Modulation:

• Innate immune activation — stimulates macrophage and neutrophil recruitment and activation
• Dendritic cell maturation — promotes antigen-presenting cell function for adaptive immune priming
• TLR (Toll-Like Receptor) modulation — fine-tunes pathogen recognition signaling
• Anti-inflammatory activity — reduces excessive inflammatory signaling preventing tissue damage from overactive immune responses
• Immune homeostasis — balances pro- and anti-inflammatory signals for optimal immune function

Wound Healing & Tissue Repair:

• LL-37 wound healing — promotes keratinocyte migration and proliferation for accelerated wound closure
• Angiogenesis stimulation — promotes VEGF-driven new blood vessel formation improving nutrient supply to healing tissue
• Fibroblast activation — stimulates collagen production and tissue remodeling
• Re-epithelialization — accelerates restoration of epithelial barrier integrity

Additional Research Applications:

• Autoimmune disease — documented role in lupus, psoriasis, and rosacea pathology — relevant for both disease mechanism research and therapeutic development
• Cancer research — complex dual role; anti-tumor activity documented in some models while pro-tumorigenic in others — active research area
• Reproductive biology — expressed in reproductive tract; documented role in sperm function and implantation research
• Respiratory research — expressed in lung epithelium; relevant for respiratory infection and COPD research

LL 37 Immune Peptide – Unique Immunomodulatory Profile

As an LL 37 immune peptide, LL-37 uniquely bridges innate and adaptive immunity — a capability that distinguishes it from all conventional immunomodulatory compounds:

• Chemokine induction — stimulates CXCL8, CXCL10, and CCL2 production, orchestrating immune cell recruitment to infection sites
• Mast cell degranulation modulation — regulates allergic inflammatory responses
• NK cell activation — enhances natural killer cell cytotoxicity
• T-cell polarization — influences Th1/Th17 immune balance relevant for autoimmune and infection research

LL 37 Peptide Dosage – Research Protocol Guide

The LL 37 peptide dosage parameters referenced across published research:

• In vitro antimicrobial research: 1–32 μg/ml (MIC determination studies)
• Wound healing research: Topical application at 1–10 μg/ml in appropriate carrier vehicle
• In vivo subcutaneous research: 1–5mg/kg in published animal models
• Administration routes: Topical (wound healing), subcutaneous (systemic), intranasal (respiratory), intraperitoneal (in vivo models)
• Reconstitution: Dissolve in sterile PBS or saline; store at -20°C lyophilized; reconstituted solutions stable 7 days at 4°C; protect from light
• Important: LL-37 can form aggregates at high concentrations — vortex gently before use; avoid repeated freeze-thaw cycles

Why Collagenpeptideseu Is the Best LL-37 Supplier

Finding a reliable LL  37 supplier requires absolute confidence in synthesis accuracy — LL-37’s amphipathic alpha-helical structure must be precisely constructed for membrane-active antimicrobial function. Incorrect synthesis eliminates both antimicrobial and immunomodulatory activity entirely. When you LL 37 peptide buy from Collagenpeptideseu, you receive:

• ✔ Correctly synthesized pharmaceutical-grade LL-37 — verified 37-amino acid sequence and antimicrobial membrane activity confirmed
• ✔ Third-party batch testing — independent purity, identity, and concentration verification
• ✔ Proper lyophilization — maximum peptide stability and extended shelf life guaranteed
• ✔ Competitive global pricing — best value for premium antimicrobial research peptides
• ✔ Discreet, tamper-proof international packaging — protecting peptide integrity throughout transit
• ✔ Real-time shipment tracking — full order visibility from purchase to delivery
• ✔ Expert multilingual support — English, German, French, Spanish, and Portuguese

Buy LL 37 Online Today

Whether you’re researching antimicrobial resistance mechanisms, innate immunity, wound healing biology, host defense peptide pharmacology, biofilm disruption, or the comprehensive immunomodulatory activity of human cathelicidin peptides, LL-37 delivers the most biologically significant and functionally versatile antimicrobial research peptide available in 2025.

Order now at Collagenpeptideseu — the most trusted source for pharmaceutical-grade LL-37 worldwide — and unlock the full research potential of the human body’s most important antimicrobial peptide.

This product is intended for research purposes only. Always conduct research in accordance with applicable institutional and regulatory guidelines.